Find Resources
Emerging Practices that show potential to achieve desirable public health outcomes in a specific real-life setting and produce early results that are consistent with the objectives of the activities and thus indicate effectiveness.
RELEASE DATE:
Journal
This editorial from The Lancet Respiratory Medicine discusses the growing public health crisis of Long COVID. It highlights that over 65 million people worldwide are estimated to have post-acute sequelae of COVID-19, and there is an urgent need for preventive, rehabilitative, and therapeutic strategies to address this issue. The article emphasizes the importance of vaccination against SARS-CoV-2 in reducing the risk of Long COVID and mentions the potential benefits of early outpatient treatment in preventing it. However, challenges remain in defining Long COVID, diagnosing it reliably, and understanding its causes and mechanisms. The article calls for large-scale research initiatives to explore these aspects, identify diagnostic and prognostic biomarkers, and develop targeted interventions. It also emphasizes the importance of considering the needs of vulnerable populations and providing patient-centered care for Long COVID.
Promising Practices that show evidence of effectiveness in improving public health outcomes in a specific real-life setting, as indicated by achievement of aims consistent with the objectives of the activities, and are suitable for adaptation by other communities.
RELEASE DATE:
Press Release
The U.S. Department of Health and Human Services has announced the establishment of the Office of Long COVID Research and Practice to address the long-term effects of COVID-19. This office will coordinate the government’s response to Long COVID, including associated conditions and the implementation of a National Research Action Plan. Over 14 federal departments and divisions are working together to reduce the impact of Long COVID and improve the quality of life for those affected. Additionally, the National Institutes of Health has launched the RECOVER Initiative, a $1.15 billion research program focused on understanding, treating, and preventing Long COVID. The initiative involves large-scale studies and clinical trials to develop interventions for the condition.